Debashis Ghosh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Debashis Ghosh has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Mary Erman
Hauptman-Woodward Medical Research Institute, Buffalo, New York
7 shared publicationsWalter Pangborn
Hauptman-Woodward Medical Research Institute, Buffalo, New York
5 shared publicationsDaniel J. Thiel
From the ‡Hauptman-Woodward Medical Research Institute, Buffalo, New York 14203, the §Roswell-Park Cancer Institute, Buffalo, New York 14263, the **Pontificia Universidad Catolica de Chile, Santiago, Chile, the §§Karolinska Institutet, Stockholm SE-17177, Sweden, and the ¶¶Cornell High Energy Synchrotron Source, Ithaca, New York 14853
3 shared publicationsHans Jörnvall
From the ‡Hauptman-Woodward Medical Research Institute, Buffalo, New York 14203, the §Roswell-Park Cancer Institute, Buffalo, New York 14263, the **Pontificia Universidad Catolica de Chile, Santiago, Chile, the §§Karolinska Institutet, Stockholm SE-17177, Sweden, and the ¶¶Cornell High Energy Synchrotron Source, Ithaca, New York 14853
3 shared publicationsMark Sawicki
3 shared publicationsJaime Eyzaguirre
From the ‡Hauptman-Woodward Medical Research Institute, Buffalo, New York 14203, the §Roswell-Park Cancer Institute, Buffalo, New York 14263, the **Pontificia Universidad Catolica de Chile, Santiago, Chile, the §§Karolinska Institutet, Stockholm SE-17177, Sweden, and the ¶¶Cornell High Energy Synchrotron Source, Ithaca, New York 14853
2 shared publications
Latest Publications
- 1 February 2010
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 118 (4-5) , 197-202
X-ray structure of human aromatase reveals an androgen-specific active site
- 1 February 2010
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 118 (4-5) , 197-202
X-ray structure of human aromatase reveals an androgen-specific active site
- Top Cited PapersOpen Access
- 8 January 2009
- Published by Springer Nature in Nature
- Vol. 457 (7226) , 219-223
Structural basis for androgen specificity and oestrogen synthesis in human aromatase
Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens. This enzyme catalyses the three-step conversion of androstenedione, testosterone, and 16α-hydroxytestosterone to oestrone, 17β-oestradiol, and 17β,16α-oestriol (respectively). Inhibitors of aromatase are potential therapeutics for oestrogen-dependent breast cancer. In this paper, Ghosh et al. solve the X-ray crystal structure of the first natural mammalian, full-length P450, human placental aromatase. The locations of catalytically important residues shed new light on the reaction mechanism of this enzyme, and it may be possible to utilize this information to develop new aromatase inhibitors. Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens. This paper solves the X-ray crystal structure of the first natural mammalian, full-length P450, human placental aromatase. Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens1,2,3. Aromatase inhibitors therefore constitute a frontline therapy for oestrogen-dependent breast cancer3,4. In a three-step process, each step requiring 1 mol of O2, 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16α-hydroxytestosterone to oestrone, 17β-oestradiol and 17β,16α-oestriol, respectively1,2,3. The first two steps are C19-methyl hydroxylation steps, and the third involves the aromatization of the steroid A-ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full-length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen-specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino-terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme’s androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatase inhibitors.
- 8 January 2009
- Published by Springer Nature in Nature
- Vol. 457 (7226) , 219-223
Top Cited PapersOpen AccessStructural basis for androgen specificity and oestrogen synthesis in human aromatase
Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens. This enzyme catalyses the three-step conversion of androstenedione, testosterone, and 16α-hydroxytestosterone to oestrone, 17β-oestradiol, and 17β,16α-oestriol (respectively). Inhibitors of aromatase are potential therapeutics for oestrogen-dependent breast cancer. In this paper, Ghosh et al. solve the X-ray crystal structure of the first natural mammalian, full-length P450, human placental aromatase. The locations of catalytically important residues shed new light on the reaction mechanism of this enzyme, and it may be possible to utilize this information to develop new aromatase inhibitors. Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens. This paper solves the X-ray crystal structure of the first natural mammalian, full-length P450, human placental aromatase. Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens1,2,3. Aromatase inhibitors therefore constitute a frontline therapy for oestrogen-dependent breast cancer3,4. In a three-step process, each step requiring 1 mol of O2, 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16α-hydroxytestosterone to oestrone, 17β-oestradiol and 17β,16α-oestriol, respectively1,2,3. The first two steps are C19-methyl hydroxylation steps, and the third involves the aromatization of the steroid A-ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full-length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen-specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino-terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme’s androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatase inhibitors.
- Open Access
- 13 December 2007
- Vol. 13, 2275-2281
Purification of the full-length Xenopus interphotoreceptor retinoid binding protein and growth of diffraction-quality crystals
Interphotoreceptor retinol-binding protein (IRBP), composed of two or four homologous modules in tandem, plays an important role in retinoid trafficking between the retinal pigmented epithelium, photoreceptors, and Müller cells. The exact nature of this role is not yet clear. Attempts to purify the full-length retinal IRBP to homogeneity for crystallization purposes have largely been unsuccessful, owing primarily to instability and denaturation of the protein at high concentrations in aqueous media. A bacterial expression system was used for the production of the recombinant full-length four modules-containing Xenopus IRBP (xIRBP; 1197 amino acids; 131 kDa). An optimized purification strategy and the presence of molar excesses of a thiol-based reducing agent yielded highly pure xIRBP in a soluble, stable and active form, free of its fusion partner. Binding of all-trans retinol was characterized by fluorescence spectroscopy monitoring ligand-fluorescence enhancement, quenching of endogenous protein fluorescence, and energy transfer. We grew the first diffraction-quality crystal of xIRBP. We have gathered diffraction data from these crystals to 2.46 Å resolution, sufficient to yield an atomic model of the tertiary structure of IRBP. Retinol-binding results determined by fluorescence spectroscopy show roughly one retinol-binding site per polypeptide chain. The binding stoichiometry taken together with modeling data suggest that not all modules are functionally equivalent. Determination of the full-length IRBP structure will be a significant breakthrough in understanding the functional roles of IRBP in the visual cycle. The advances presented here will not only lead to the structure of the full-length IRBP, but will allow us to understand how the modules interact in the function of IRBP. Furthermore, these studies will allow characterization of the ligand-binding site(s) with bound ligand(s).
- 13 December 2007
- Vol. 13, 2275-2281
Open AccessPurification of the full-length Xenopus interphotoreceptor retinoid binding protein and growth of diffraction-quality crystals
Interphotoreceptor retinol-binding protein (IRBP), composed of two or four homologous modules in tandem, plays an important role in retinoid trafficking between the retinal pigmented epithelium, photoreceptors, and Müller cells. The exact nature of this role is not yet clear. Attempts to purify the full-length retinal IRBP to homogeneity for crystallization purposes have largely been unsuccessful, owing primarily to instability and denaturation of the protein at high concentrations in aqueous media. A bacterial expression system was used for the production of the recombinant full-length four modules-containing Xenopus IRBP (xIRBP; 1197 amino acids; 131 kDa). An optimized purification strategy and the presence of molar excesses of a thiol-based reducing agent yielded highly pure xIRBP in a soluble, stable and active form, free of its fusion partner. Binding of all-trans retinol was characterized by fluorescence spectroscopy monitoring ligand-fluorescence enhancement, quenching of endogenous protein fluorescence, and energy transfer. We grew the first diffraction-quality crystal of xIRBP. We have gathered diffraction data from these crystals to 2.46 Å resolution, sufficient to yield an atomic model of the tertiary structure of IRBP. Retinol-binding results determined by fluorescence spectroscopy show roughly one retinol-binding site per polypeptide chain. The binding stoichiometry taken together with modeling data suggest that not all modules are functionally equivalent. Determination of the full-length IRBP structure will be a significant breakthrough in understanding the functional roles of IRBP in the visual cycle. The advances presented here will not only lead to the structure of the full-length IRBP, but will allow us to understand how the modules interact in the function of IRBP. Furthermore, these studies will allow characterization of the ligand-binding site(s) with bound ligand(s).
- 11 June 2007
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 64 (15) , 2013-2022
Human sulfatases: A structural perspective to catalysis
The sulfatase family of enzymes catalyzes hydrolysis of sulfate ester bonds of a wide variety of substrates. Seventeen genes have been identified in this class of sulfatases, many of which are associated with genetic disorders leading to reduction or loss of function of the corresponding enzymes. Amino acid sequence homology suggests that the enzymes have similar overall folds, mechanisms of action, and bivalent metal ion-binding sites. A catalytic cysteine residue, strictly conserved in prokaryotic and eukaryotic sulfatases, is post-translationally modified into a formylglycine. Hydroxylation of the formylglycine residue by a water molecule forming the activated hydroxylformylglycine (a formylglycine hydrate or a gem-diol) is a necessary step for the enzyme’s sulfatase activity. Crystal structures of three human sulfatases, arylsulfatases A and B(ARSA and ARSB), and estrone/dehydroepiandrosterone sulfatase or steroid sulfatase (STS), also known as arylsulfatase C, have been determined. While ARSA and ARSB are water-soluble enzymes, STS has a hydrophobic domain and is an integral membrane protein of the endoplasmic reticulum. In this article, we compare and contrast sulfatase structures and revisit the proposed catalytic mechanism in light of available structural and functional data. Examination of the STS active site reveals substrate-specific interactions previously identified as the estrogen-recognition motif. Because of the proximity of the catalytic cleft of STS to the membrane surface, the lipid bilayer has a critical role in the constitution of the active site, unlike other sulfatases.
- 11 June 2007
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 64 (15) , 2013-2022
Human sulfatases: A structural perspective to catalysis
The sulfatase family of enzymes catalyzes hydrolysis of sulfate ester bonds of a wide variety of substrates. Seventeen genes have been identified in this class of sulfatases, many of which are associated with genetic disorders leading to reduction or loss of function of the corresponding enzymes. Amino acid sequence homology suggests that the enzymes have similar overall folds, mechanisms of action, and bivalent metal ion-binding sites. A catalytic cysteine residue, strictly conserved in prokaryotic and eukaryotic sulfatases, is post-translationally modified into a formylglycine. Hydroxylation of the formylglycine residue by a water molecule forming the activated hydroxylformylglycine (a formylglycine hydrate or a gem-diol) is a necessary step for the enzyme’s sulfatase activity. Crystal structures of three human sulfatases, arylsulfatases A and B(ARSA and ARSB), and estrone/dehydroepiandrosterone sulfatase or steroid sulfatase (STS), also known as arylsulfatase C, have been determined. While ARSA and ARSB are water-soluble enzymes, STS has a hydrophobic domain and is an integral membrane protein of the endoplasmic reticulum. In this article, we compare and contrast sulfatase structures and revisit the proposed catalytic mechanism in light of available structural and functional data. Examination of the STS active site reveals substrate-specific interactions previously identified as the estrogen-recognition motif. Because of the proximity of the catalytic cleft of STS to the membrane surface, the lipid bilayer has a critical role in the constitution of the active site, unlike other sulfatases.
- Open Access
- 1 January 2007
- Published by Springer Nature in BMC Biochemistry
- Vol. 8 (1) , 15
Module structure of interphotoreceptor retinoid-binding protein (IRBP) may provide bases for its complex role in the visual cycle – structure/function study of Xenopus IRBP
Interphotoreceptor retinoid-binding protein's (IRBP) remarkable module structure may be critical to its role in mediating the transport of all-trans and 11-cis retinol, and 11-cis retinal between rods, cones, RPE and Müller cells during the visual cycle. We isolated cDNAs for Xenopus IRBP, and expressed and purified its individual modules, module combinations, and the full-length polypeptide. Binding of all-trans retinol, 11-cis retinal and 9-(9-anthroyloxy) stearic acid were characterized by fluorescence spectroscopy monitoring ligand-fluorescence enhancement, quenching of endogenous protein fluorescence, and energy transfer. Finally, the X-ray crystal structure of module-2 was used to predict the location of the ligand-binding sites, and compare their structures among modules using homology modeling.
- 1 January 2007
- Published by Springer Nature in BMC Biochemistry
- Vol. 8 (1) , 15
Open AccessModule structure of interphotoreceptor retinoid-binding protein (IRBP) may provide bases for its complex role in the visual cycle – structure/function study of Xenopus IRBP
Interphotoreceptor retinoid-binding protein's (IRBP) remarkable module structure may be critical to its role in mediating the transport of all-trans and 11-cis retinol, and 11-cis retinal between rods, cones, RPE and Müller cells during the visual cycle. We isolated cDNAs for Xenopus IRBP, and expressed and purified its individual modules, module combinations, and the full-length polypeptide. Binding of all-trans retinol, 11-cis retinal and 9-(9-anthroyloxy) stearic acid were characterized by fluorescence spectroscopy monitoring ligand-fluorescence enhancement, quenching of endogenous protein fluorescence, and energy transfer. Finally, the X-ray crystal structure of module-2 was used to predict the location of the ligand-binding sites, and compare their structures among modules using homology modeling.
- 24 December 2004
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1739 (1) , 1-4
Mutations in X-linked ichthyosis disrupt the active site structure of estrone/DHEA sulfatase
- 24 December 2004
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1739 (1) , 1-4
Mutations in X-linked ichthyosis disrupt the active site structure of estrone/DHEA sulfatase
- Open Access
- 1 May 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (21) , 18457-18463
Porcine Carbonyl Reductase
- 1 May 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (21) , 18457-18463
Open AccessPorcine Carbonyl Reductase
- Open Access
- 1 April 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (14) , 11159-11166
Multiple Conformations of Catalytic Serine and Histidine in Acetylxylan Esterase at 0.90 Å
- 1 April 2001
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (14) , 11159-11166
Open AccessMultiple Conformations of Catalytic Serine and Histidine in Acetylxylan Esterase at 0.90 Å
- 30 January 2001
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 130-132, 637-650
Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17β-hydroxysteroid dehydrogenase 1
- 30 January 2001
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 130-132, 637-650
Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17β-hydroxysteroid dehydrogenase 1
- 1 May 1999
- Published by Elsevier in Molecular Immunology
- Vol. 36 (7) , 423-432
Structure of an activity suppressing Fab fragment to cytochrome P450 aromatase: insights into the antibody–antigen interactions
- 1 May 1999
- Published by Elsevier in Molecular Immunology
- Vol. 36 (7) , 423-432
Structure of an activity suppressing Fab fragment to cytochrome P450 aromatase: insights into the antibody–antigen interactions